Sjögren syndrome (SjS) is a systemic autoimmune disease that primarily affects the exocrine
glands (mainly the salivary and lacrimal glands) and results in the severe dryness of …

The term “mixed connective tissue disease” (MCTD) concerns a systemic autoimmune
disease typified by overlapping features between two or more systemic autoimmune diseases …

… Author links open overlay panel Matthieu Groh a , Christian Pagnoux b , Chiara Baldini c ,
… Chiara Baldini: fees paid to the institution by GSK for being an investigator in a clinical trial …

Objective. To develop valid instruments for the assessment of disease-related damage and
disease activity in Sjögren’s syndrome (SS). Methods. Data on 206 patients with primary SS …

Among anti-nuclear antibodies, anti-Sm and anti-RNP antibodies are of the utmost importance
in clinical practice. Anti-Sm antibodies are directed against 7 proteins (B/B′, D1, D2, D3, …

Objective. The aims of this study were to describe the clinical presentation of primary SS (pSS)
in a large cohort of patients by assessing the prevalence of the patient subgroups at high …

Objectives To define the biomarkers associated with lymphoproliferation in primary Sjögren’s
syndrome (pSS) by distinguishing in separate groups the two best-recognized non-…

Objective Systemic autoimmune diseases, in particular systemic lupus erythematosus and
rheumatoid arthritis, are characterized by a high risk of premature cardiovascular ( CV ) events…

Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare inflammatory disease of unknown
cause. 30% of patients have anti-neutrophil cytoplasmic antibodies (ANCA) specific for …